New Hepatitis C Drug Incivek Gets FDA Approval
The FDA has approved Incivek as an add-on to current interferon/ribavirn therapy for hepatitis C infection. Like Victrelis, also approved this month, Incivek greatly boosts the cure rate for hepatitis C.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
